I have much more respect for russian papers in pharmacology in general than for your average american study. There are many reasons to this: 1) a lot of their r

I have much more respect for russian papers in pharmacology in general than for your average american study. There are many reasons to this: 1) a lot of their research is public. They don't have broken incentives, e.g. they can study the tech that the body use, such as peptides. Big pharma can't leverage endogenous peptides because they're not patentable, a true tragedy that considerably sets back medecine progress. 2) they study outside of the boxe things, they are not afraid to do human trials, they have expertise in gerontology (oxidative stress, bioenergetics, etc) which are often very lacking in american studies. also, those russian researches are generally validated by non-russian working groups. as an example, many of the favorites nootropics people experience have been discovered in russia (racetams, bromantane, etc)